Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study (Q34498634)

2 August 2017

title

Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study (English)

1 reference

2 August 2017

1 reference

1 reference

Rosalind Eeles

0 references

Gareth Evans

0 references

Susan M Domchek

1 reference

2 August 2017

Susan L Neuhausen

1 reference

2 August 2017

Olufunmilayo I Olopade

1 reference

2 August 2017

Claudine Isaacs

1 reference

2 August 2017

Mary B Daly

1 reference

2 August 2017

Judy E Garber

1 reference

2 August 2017

Tara M Friebel

1 reference

2 August 2017

Theresa Wagner

1 reference

2 August 2017

Ellen Matloff

1 reference

2 August 2017

Gail E Tomlinson

1 reference

2 August 2017

Laura Van't Veer

1 reference

2 August 2017

Henry T Lynch

1 reference

2 August 2017

Barbara L Weber

1 reference

2 August 2017

Timothy R Rebbeck

1 reference

2 August 2017

publication date

1 March 2006

1 reference

Lancet Oncology Commission

2 August 2017

published in

1 reference

2 August 2017

1 reference

2 August 2017

1 reference

2 August 2017

page(s)

223-229

1 reference

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970585-X

7 January 2021

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970585-X

7 January 2021

Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970585-X

7 January 2021

Knowledge, attitudes, and utilization of BRCA1/2 testing among women with early-onset breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970585-X

7 January 2021

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970585-X

7 January 2021

Potential for bias in studies on efficacy of prophylactic surgery for BRCA1 and BRCA2 mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970585-X

7 January 2021

Prophylactic mastectomy for BRCA1/2 carriers: progress and more questions

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970585-X

7 January 2021

Bias in intervention studies that enroll patients from high-risk clinics

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970585-X

7 January 2021

Should women at increased risk for breast and ovarian cancer be randomized to prophylactic surgery? An ethical and empirical assessment.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970585-X

7 January 2021

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970585-X

7 January 2021

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970585-X

7 January 2021

Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970585-X

7 January 2021

10.1016/S1470-2045(06)70585-X

Identifiers

DOI

1 reference

release_pzonejxii5cbxovk3sepljjfym

2 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pzonejxii5cbxovk3sepljjfym

24 November 2022

mapped directly with Wikidata item

1 reference